Rosbach vor der Höhe, Germany

Bernhard Hoffmann

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Metax Institut Fur Diatetik Gmbh. Active years: 2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernhard Hoffmann: Innovator in Dietary Protein Solutions

Introduction

Bernhard Hoffmann is a notable inventor based in Rosbach vor der Höhe, Germany. He has made significant contributions to the field of dietary proteins, particularly for medical applications. His work focuses on developing solutions for patients with specific dietary needs.

Latest Patents

Hoffmann holds a patent for a "Phenylalanine-free protein for the treatment of PKU." This invention provides a recombinant dietary protein that is free of phenylalanine and boasts a high biological value. The patent also includes a vector encoding the dietary protein, microorganisms that express the protein, and methods for its production. Additionally, it outlines a dietary composition that can be used as a medicament or food for special medical purposes for patients with phenylalanine accumulation in their bodies.

Career Highlights

Hoffmann is associated with Metax Institut für Diätetik GmbH, where he applies his expertise in dietary solutions. His innovative approach has positioned him as a key figure in the development of specialized dietary proteins.

Collaborations

Hoffmann has collaborated with notable colleagues, including Stefan Rasche and Stefan Schillberg, to advance research and development in dietary protein solutions.

Conclusion

Bernhard Hoffmann's contributions to the field of dietary proteins, particularly for patients with PKU, highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of specialized dietary solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…